Options Trading Strategies on Pfizer: Analysis of Two Different Tactics

Overall, in the stock market landscape, options trading is an intriguing tool for those seeking opportunities beyond traditional stock investments. Pfizer (PFE) recently provided an interesting case study on how options traders move in response to specific market situations. The unusual activity recorded in the pharmaceutical stock highlighted two particularly relevant strategic approaches for understanding the dynamics of financial options.

When the Options Market Speaks: Pfizer’s Extraordinary Activity

The phenomenon observed in Pfizer’s options market was anything but ordinary. The put with a strike at $29 and expiration on March 20 showed an exceptionally high volume/open interest ratio (Vol/OI) of 210.16, significantly surpassing activity in other options in the market. This data caught the attention of traders and analysts, as such a ratio indicates a massive influx of contracts in a short period.

To better understand the context: Pfizer has a market capitalization of $144 billion and a recent complex history. Once a main beneficiary of COVID-19 demand, the stock later plummeted, losing about 59% from the peak of $61.71 reached in 2021. Currently, the stock fluctuates around $25, posing a challenge for traditional investors looking for compelling reasons to buy.

The average 30-day options volume for Pfizer is around 142,695 contracts. The activity recorded was 1.39 times higher than this average, marking the most active day since early December. However, these figures remain below the extraordinary volumes seen on earnings release days, when volumes exceeded 890,000 contracts.

Two Approaches to Pfizer Options Trading

The extraordinary activity in Pfizer options trading revealed two distinct operational strategies, both centered around the $29 strike price with the same expiration date. Although the movement involved the put, it was the combination with the call that uncovered the underlying tactical intent.

On average, Pfizer’s options volume is moderate, but during specific sessions, traders focus their movements on well-defined strategies. The simultaneous presence of high volume on both the put and call at the same strike suggests a deliberate trading architecture, where the choice between two different approaches depends on market outlook and risk profile.

The Long Straddle: Betting on Volatility

The first emerging strategy from Pfizer options trading is the Long Straddle, a sophisticated technique designed for those who believe the market will move significantly in either direction but remain uncertain about the specific direction. This approach involves buying both a put and a call at the same strike ($29 in this case).

The Long Straddle mechanism is elegant in its simplicity: the trader profits from a large move in either direction. If the stock price at expiration exceeds $33.38 (the breakeven point on the upside), profit begins to grow on the call. Conversely, if the price drops below $24.62 (the breakeven point on the downside), profit comes from the put.

For this specific trade, the net cost (debit) was $4.38 per share, or $438 per contract. With 71 days remaining until expiration, this timeframe offers an ideal window for options trading: enough for significant moves, but not so long as to incur excessive time decay (the ideal timeframe for many traders ranges between 30 and 45 days).

The theoretical probability that the Long Straddle will be profitable was estimated at around 37%, not particularly high but offset by potential substantial gains. If the stock moved downward by 6.96% (the expected move), the price would reach $23.53, generating a profit of $89 (the difference between the price and the downside breakeven, multiplied by 100 shares). Annualized over 71 days, this yields a return of 128.0%, a respectable result in options trading.

The Bull Put Spread: A Conservative Bullish Strategy

The second strategy in Pfizer options trading is the Bull Put Spread. This technique is built by those with a bullish outlook on the stock who want to limit potential risk.

The Bull Put Spread involves selling the $29 put (collecting a premium of $390) and simultaneously buying a $26 put (costing $156) as protection. The immediate net credit is $234 per contract. This credit represents the maximum potential profit if the stock closes above $29 at expiration.

Risk management is central to this approach. The maximum potential loss is limited to $266 per contract (the difference between the strikes times 100, minus the initial credit), establishing a risk/reward ratio of just 0.28 to 1. In other words, the trader risks $28 for every $100 of potential profit—considered favorable by many conservative operators.

If the stock closes above $29 at expiration, the trader realizes the full profit of $234, equivalent to a 354.55% return on the initial credit, or 1,848.73% annualized. Although the success probability is estimated at around 33%, the breakeven point on the downside is at $26.66, only 4.84% above the current price of $25.43, well within the expected 6.96% move.

Comparing Strategies and Investor Choice

These two options strategies represent radically different investment philosophies, reflecting ongoing debates in the derivatives market.

The Long Straddle appeals to those who believe in a significant volatility move but are uncertain about the direction. It’s a symmetric bet on volatility, where both bullish and bearish positions have equal profit opportunities. However, it requires a large move to surpass the breakeven threshold.

The Bull Put Spread, on the other hand, is suited for bullish traders who want to collect premiums (initial income) while maintaining controlled risk. It performs best in stable or slightly bullish markets, where the stock doesn’t fall but rises or remains sideways. It’s a “premium collection” strategy where time works in favor of the seller.

In terms of risk profile, the Bull Put Spread offers a more favorable risk/reward ratio (0.28:1), while the Long Straddle requires a more substantial price move for profitability. For conservative investors, the Bull Put Spread is generally a more suitable choice; for those speculating on high volatility, the Long Straddle offers the desired asymmetry.

This case study of Pfizer options trading demonstrates how two different operators, observing the same market environment, can adopt diametrically opposed solutions based on their outlook and risk tolerance. The key lies in understanding the underlying mechanisms of each options strategy and aligning them with personal objectives and risk profiles.